9 results
8-K
EX-99.1
TLPH
Talphera Inc.
17 May 21
AcelRx Pharmaceuticals Reports First Quarter 2021 Financial Results
4:10pm
profile for all demographic subgroups following the dosing of DSUVIA. See Cautionary Statements section below.
In March 2021, AcelRx announced
8-K
EX-1.1
n509v
21 Jan 21
Entry into a Material Definitive Agreement
5:29pm
8-K
EX-99.1
8kbvees3n7rcgnipj4
6 Nov 19
AcelRx Pharmaceuticals Reports Third Quarter 2019 Financial Results
4:26pm
8-K
EX-1.1
b9cdb7tp
13 Nov 18
Other Events
5:18pm
8-K
EX-1.1
fwjsw2a0n91t0c1ge
13 Jul 18
Other Events
4:03pm
- Prev
- 1
- Next